Beta Drugs Ltd share price logo

Beta Drugs Ltd Share Price (BETA)

₹1934.60.53%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Beta Drugs Ltd Stock Performance

as on August 25, 2025 at 11:18 AM IST

  • Day's Low

    Day's High

    ₹1,900
    ₹1,939
    downward going graph

    1.79%

    Downside

    0.23%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹1,285.71
    ₹2,215.24
    downward going graph

    33.54%

    Downside

    14.51%

    Upside

    downward going graph
Previous Close₹1,945.00
Open₹1,934.60
Volume1,680.00
Upper Circuit₹2,334.00
Lower Circuit₹1,556.00
Day's Low1,900
Day's High1,939
52 Week Low1,285.71
52 Week High2,215.24
1 Month Return+ 13.73 %
3 Month Return+ 5.19 %
1 Year Return+ 37.02 %
3 Year Return+ 158.53 %
5 Year Return+ 2247.33 %

Beta Drugs Ltd Stock Fundamentals & Key Indicators

Check Beta Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹1,963.39 Cr

Return on Equity (ROE)

20.67

PE Ratio (TTM)

0

Return on capital employed (ROCE)

26.6

Beta (LTM)

1.43

P/B Ratio

10.22

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

0

EPS (TTM)

37.9

Sector

Pharmaceuticals

Book Value

163.43

Technical Analysis

Beta Drugs Ltd Stock's Interest Amongst Investors

-11%

Period Aug 25, 2025 to Jul 26, 2025. Change in 30 Days vs previous period

Search interest for Beta Drugs Ltd Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Beta Drugs Ltd Financial Results

Get the annual and quarterly financial summary of Beta Drugs Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

118 (0%)158 (34%)198 (26%)254 (28%)
Total Liabilities

(in ₹ Cr)

49 (0%)66 (34%)76 (15%)97 (28%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

6 (0%)12 (90%)19 (62%)10 (45%)21 (107%)

Beta Drugs Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Beta Drugs Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
66.73%
0.00
Foreign Institutions
0.9%
0.00
Mutual Funds
0%
0.00
Retail Investors
32.11%
-0.29
Others
0.26%
56.03

Beta Drugs Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Beta Drugs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA1,963.39449.47%0.5636295
NA47.9824.74%0.50167
NA61.0127.84%0.00537
BUY2,841.93-8.98%0.531012,079
NA161.47-2.59%0.00-2050

Beta Drugs Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Beta Drugs Ltd.

  • Beta Drugs Ltd Shows Strong Growth Amid Discounted Trading - 08 Apr, 2025

    Beta Drugs Ltd, specializing in oncology, is trading at a 17% discount from its 52-week high. The company reported a 28% revenue increase and a 20% rise in net profit for H1 FY25, showcasing solid financials and growth potential. With strong domestic and international sales, it remains a key player in the pharmaceutical sector.

Insights on Beta Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BETA stock has moved up by 13.7%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BETA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BETA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.73% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.90% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 32.20% to 32.11% in Jun 2025 quarter

About Beta Drugs Ltd

Beta Drugs Limited is a part of the Adley Group, established in 1985 by its promoter Vijay Batra. It is a pharmaceutical formulation manufacturing company that produces and markets drugs to domestic and international customers. The Company specializes in the production of oncology products such as anticancer tablets, capsules, injections and lyophilized injections. With a portfolio of over 50 products catering to various oncology diseases such as breast cancer, brain cancer, bone cancer, lung cancer, mouth cancer, head and neck cancer, prostate cancer, haematology and cervics oeaophagus, Beta Drugs is an important contributor to the healthcare industry. The Company was originally incorporated in Himachal Pradesh in 2005 as a private limited company and was converted into a public limited company in 2017. Under the charge of Vijay Batra, Beta Drugs has become a well-recognized and trusted international healthcare brand.

Listing date: 12 Oct, 2017
Chairperson Name: Rahul Batra
OrganisationBeta Drugs Ltd
IndustryPharmaceuticals
CEORahul Batra
E-voting on sharesClick here to vote

FAQs

What is Beta Drugs Ltd share price today?

Beta Drugs Ltd share price today stands at ₹1934.6, Open: ₹1934.6, Previous Close: ₹1945, High: ₹1939, Low: ₹1900, 52 Week High: ₹2215.24, 52 Week Low: ₹1285.71 as on .

How to buy Beta Drugs Ltd shares ?

To buy Beta Drugs Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BETA or Beta Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Beta Drugs Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Beta Drugs Ltd?

Today's traded volume of Beta Drugs Ltd is 1,680.00. Which means that 1,680.00 shares of Beta Drugs Ltd were bought and sold on the stock market during today's trading session.

What is Beta Drugs Ltd's market cap today?

Today's market capitalisation of Beta Drugs Ltd is ₹1,963.39 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Beta Drugs Ltd?

Beta Drugs Ltd’s 52 week high is ₹2215.24 and 52 week low is ₹1285.71. The current share price of Beta Drugs Ltd is ₹1934.6, which is -12.67% down from its 52 week high and 50.47% up from its 52 week low.